DNA Technology Provides Novel Strategy for Delivery of Complex Anti-HIV Agent
Philadelphia, PA — Scientists at The Wistar Institute have applied their synthetic DNA technology to engineer a novel eCD4-Ig anti-HIV agent and to enhance its potency in vivo, providing a new simple...